Functionalized PEG Linkers Support Expanding Bioconjugation and Bioorthogonal Chemistry Applications

WATERTOWN, MA — As bioconjugation and bioorthogonal chemistry continue to develop across drug discovery, molecular imaging, biomolecule labeling, and therapeutic research, researchers are increasingly looking for functionalized linkers that can be adapted to different conjugation strategies. Biopharma PEG is supporting these applications with a broad portfolio of functionalized polyethylene glycol (PEG) linkers and custom PEG synthesis capabilities.

PEG linkers can serve as molecular spacers while providing defined reactive groups for coupling with proteins, peptides, small molecules, fluorescent probes, and other biomolecules. The choice of PEG architecture, chain length, and terminal functionality can influence the design and properties of the resulting conjugate.

Among the commonly used approaches, azide–alkyne chemistry provides researchers with complementary options for both copper-catalyzed and copper-free conjugation. Biopharma PEG offers functionalized PEG building blocksdesigned for these applications, including azide, alkyne, DBCO, and BCN PEG derivatives.

Azide and alkyne PEGs can be used in CuAAC-based conjugation workflows, while DBCO and BCN derivatives provide options for strain-promoted azide–alkyne cycloaddition (SPAAC), which can be useful when copper-free reaction conditions are preferred.

“Different bioconjugation projects can require very different linker structures and functional groups,” said a chemist at Biopharma PEG. “We hope to provide high-purity PEG linkers that give researchers more practical choices when developing click chemistry and bioorthogonal conjugation workflows.”

Beyond click chemistry, functionalized PEG linkers can support a range of research applications, including protein and peptide conjugation, molecular labeling, biomaterial modification, drug delivery research, and the development of conjugated therapeutic systems.

Biopharma PEG provides both monodispersed and polydispersed PEG derivatives, with a range of molecular weights, architectures, and functional groups. The company also provides custom synthesis for projects requiring specific PEG structures or terminal functionalities.

The portfolio includes PEG derivatives with commonly used reactive groups such as amines, thiols, NHS esters, maleimides, carboxylic acids, azides, alkynes, DBCO, and BCN. These options allow researchers to select PEG building blocks according to their conjugation chemistry and experimental requirements.

“Researchers often need more than a standard linker when moving from an initial experiment toward a more defined development program,” the Biopharma PEG chemist added. “Our focus is to provide reliable PEG materials and work with researchers on structures that fit their specific chemistry and development needs.”

Biopharma PEG supports academic, biotechnology, and pharmaceutical research with catalog PEG derivatives and custom synthesis services, providing materials for applications ranging from early-stage laboratory research to larger-scale development.

About Biopharma PEG

Biopharma PEG Scientific Inc. is a PEG-focused biotechnology company based in Watertown, Massachusetts. The company provides high-purity PEG derivatives, functionalized PEG linkers, and custom PEG synthesis services for pharmaceutical, biotechnology, and academic research.

For more information, visit www.biochempeg.com or contact [email protected].